TerrAscend (TSNDF) Net Cash Flow Growth (1y) (2022 - 2026)
TerrAscend (TSNDF) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.62 Bn | 23.56 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | -1,020.00% |
| 10 | TerrAscend | 161.95 Mn | 161.48 Mn | 34.60 Mn | -76.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.92% |
| Dec 31, 2025 | 448.88% |
| Sep 30, 2025 | 5,931.88% |
| Jun 30, 2025 | -139.60% |
| Mar 31, 2025 | 2,470.74% |
| Dec 31, 2024 | 52.16% |
| Sep 30, 2024 | 98.94% |
| Jun 30, 2024 | 134.03% |
| Mar 31, 2024 | -96.34% |
| Dec 31, 2023 | -54.44% |
| Sep 30, 2023 | 13.92% |
| Jun 30, 2023 | 115.02% |
| Mar 31, 2023 | -55.97% |
| Dec 31, 2022 | 72.25% |
| Sep 30, 2022 | 65.27% |
| Jun 30, 2022 | 54.50% |
| Mar 31, 2022 | -91.96% |